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Synergistic action of compounds isolated from the hexane extract of Ardisia crispa root 
against tumour-promoting effect, in vitro 
 
ABSTRACT 
An isomeric mixture of α,β-amyrin (triterpene) and 2-methoxy-6-undecyl-1,4-benzoquinone 
(quinone) isolated from the Ardisia crispa root hexane (ACRH) extract was reported to 
possess anti-inflammatory properties in vivo. Considering the close association between 
inflammation and cancer, on top of the lack of antitumour study on those compounds, this 
study aimed to determine the potential of both compounds against tumour promotion in vitro, 
either as single agent or in combination. Triterpene and quinone compounds, as well as 
triterpene–quinone fraction (TQF) and ACRH were subjected to inhibition of Epstein–Barr 
virus-early antigen (EBV-EA) activation assay for that purpose. Compared with curcumin 
(positive control), inhibition against EBV-EA activation occurred in the order: ACRH>TQF 
≥ curcumin>α,β-amyrin ≥ 2-methoxy-6-undecyl-1,4-benzoquinone. These findings reported, 
for the first time, the antitumor-promoting effect of α,β-amyrin and 2-methoxy-6-undecyl-
1,4-benzoquinone from the roots of A. crispa, which was enhanced when both compounds act 
in synergy.  
Keyword: Ardisia crispa; Inflammation; Antitumour promoting; Inhibition of EBV-EA 
activation assay 
